Vascular Therapies
Vascular Therapies, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Cresskill, New Jersey, developing Sirogen, a proprietary sirolimus formulation delivered from a bioabsorbable collagen implant placed perivascularly at the time of surgery. The product is aimed at reducing surgical stenosis and improving arteriovenous fistula maturation and patency in end-stage renal disease patients who need hemodialysis vascular access. Sirolimus for dialysis vascular access carries FDA Fast Track status and Orphan Drug designation in both the United States and the European Union. The company ran the Phase 3 ACCESS trial (243 ESRD patients across 20 US sites) and the multinational Phase 3 ACCESS 2 trial, whose topline results presented in April 2025 did not meet the primary clinical fistula maturation endpoint. Vascular Therapies is a therapeutics developer, not a software company: it ships a drug-device combination product through clinical trials and regulatory review, and publishes no API, SDK, developer portal or machine-readable contract of any kind.
Vascular Therapies is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Medical Devices, and Drug Delivery.
scored 2026-11-06 · rubric v0.27.0 · Show this score on your site →
Kin Score
Kin Score
How this is scored →scored 2026-11-06 · rubric v0.27.0
<a href="https://apis.io/providers/vascular-therapies/"><img src="https://apis.io/badge/vascular-therapies/card.svg" alt="Vascular Therapies on APIs.io — Kin Score by API Evangelist"></a>Other styles, a README pill and a shields.io endpoint are on the badge page.
- Machine-Readable Contract +18 pts — api_specs includes an OpenAPI document
- MCP Server +12 pts — deployment.mode + probe verdict on the mcp/ manifest, not the pointer; an unprobed slug falls back to authorship
- Agentic Access Contract +10 pts — agentic_access artifact present (x-agentic-access), graded by author
- Machine-Readable Auth +10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
- Idempotency +9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
- Stable Error Semantics +8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
- Contract Quality scores 0.0 — up to +25.0 composite points
- Developer Ergonomics scores 0.0 — up to +20.0 composite points
- Access Clarity scores 0.0 — up to +20.0 composite points
Source (apis.yml)
aid: vascular-therapies
name: Vascular Therapies
description: 'Vascular Therapies, Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Cresskill,
New Jersey, developing Sirogen, a proprietary sirolimus formulation delivered from a bioabsorbable collagen implant placed
perivascularly at the time of surgery. The product is aimed at reducing surgical stenosis and improving arteriovenous fistula
maturation and patency in end-stage renal disease patients who need hemodialysis vascular access. Sirolimus for dialysis
vascular access carries FDA Fast Track status and Orphan Drug designation in both the United States and the European Union.
The company ran the Phase 3 ACCESS trial (243 ESRD patients across 20 US sites) and the multinational Phase 3 ACCESS 2 trial,
whose topline results presented in April 2025 did not meet the primary clinical fistula maturation endpoint. Vascular Therapies
is a therapeutics developer, not a software company: it ships a drug-device combination product through clinical trials
and regulatory review, and publishes no API, SDK, developer portal or machine-readable contract of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/vascular-therapies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
x-company-domain: vasculartx.com
x-company-domain-status: Offline as of 2026-09-02. www.vasculartx.com returns Webflow's unpublished-domain "404 - Page not
found" catch-all for the site root and for every indexed path (/about, /news, /robots.txt); the apex vasculartx.com is CNAMEd
to proxy-ssl.webflow.com and returns nginx 403 Forbidden for every path. Not wired as a Website pointer because a confirmed
dead page is a false claim, not a web presence.
x-harvest-source-listing: 'https://forgeglobal.com/vascular-therapies_stock/ — the secondary-market listing this company was
harvested from. Deliberately NOT wired as type Website: a trading-venue listing page is not the company''s own web presence,
and crediting it as one is the roadmap#56 false-credit defect.'
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source: []
generated: '2026-11-06'
method: derived
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Drug Delivery
- Clinical Trials
- Nephrology
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common: []
x-enrichment:
date: '2026-09-02'
status: minimal
artifacts_added: 1
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Vascular Therapies is a clinical-stage biopharma developing Sirogen, a sirolimus-eluting collagen implant for hemodialysis
vascular access — there is no software product to expose an API for, and its own web presence is additionally offline,
with www.vasculartx.com returning Webflow's unpublished-domain 404 catch-all on the site root and on every indexed path.
evidence:
- url: https://www.vasculartx.com/
status: 404
- url: https://www.vasculartx.com/news
status: 404
- url: https://vasculartx.com/
status: 403
- url: https://vasculartx.com/openapi.json
status: 403
- url: https://vasculartx.com/.well-known/agent-card.json
status: 403
- url: https://api.vasculartx.com/
status: 0
- url: https://developer.vasculartx.com/
status: 0
- url: https://github.com/vasculartx
status: 404
checked: '2026-09-02'
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for providers
9 MCP tools reach this
find_providersBrowse and filter every provider in the catalog.get_provider_artifactsEvery artifact this provider publishes, grouped by type.get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.get_provider_toolsEvery MCP tool they ship, with the operation each wraps.get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.get_provider_ratingPRO — composite, band, trend and facet scores.apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.resolveTurn a domain, URL or GitHub org into the provider it belongs to.find_cohortsEvery scored population of providers in the catalog.
Call it yourself
curl for this page
curl "https://apis.io/api/v1/providers/vascular-therapies"
curl "https://apis.io/api/v1/providers?limit=25"
curl "https://apis.io/api/v1/providers/vascular-therapies/operations?limit=25"
curl "https://apis.io/api/v1/providers/vascular-therapies/evidence"
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.
A second provider on the same verified email joins the account you already have.